The Clinton Foundation announced Tuesday that it has reached agreements with drug companies to reduce the costs of some HIV/Aids drugs in developing countries.
The foundation said drug makers agreed to lower the price of drugs to fight HIV that is resistant to initial treatment, and to make a once-a-day HIV/Aids pill available for less than $1 a day, the Associated Press reported.
The deals on the drugs to fight resistant HIV, reached with generic drug makers Cipla Ltd. and Matrix Laboratories Ltd., are expected to achieve average savings of 50 percent in middle-income countries and 25 percent in low-income countries, said former US President Bill Clinton.
The agreement on the $1 once-a-day pills that combine the drugs efavirenz, lamivudine and tenofovir is 45 percent less than the current rate available for low-income countries and 67 percent less than the current price for many middle-income countries, the AP reported. – (HealthDayNews)